Purpose: Reactive oxygen species (ROS) activate inflammatory pathways in several organs, including the retina. More recent work has shown that ROS activate the NOD-like receptor protein 3 (NLRP3) inflammasome pathway proteins. We recently showed that the exchange protein activated by cAMP 1 (Epac1) and protein kinase A (PKA) regulates NLRP3 proteins in the retina. Our goal was to determine whether Epac1 and PKA reduce ROS and NLRP3 inflammasome proteins.
Methods: We used human primary retinal endothelial cells (RECs) grown in normal glucose (5 mM) and stimulated in normal glucose with hydrogen peroxide (HO) to induce ROS and measured NLRP3 pathway proteins. In some groups, we treated cells with an Epac1 or a PKA agonist in addition to HO treatment to determine whether Epac1 and PKA reduced ROS and induced NLRP3 pathway proteins.
Results: The data showed that 500 µM HO was the optimal dose to increase ROS in RECs. In RECs treated with HO, NLRP3 pathway proteins were increased, which were significantly reduced by cotreatment with PKA or Epac1 agonists. HO significantly increased NIMA-related kinase 7 (Nek7) and purinergic 2X7 receptor 7 (P2X7) levels, which were blocked by Epac1 and PKA agonists.
Conclusions: Taken together, these data suggest that Epac1 and PKA reduce retinal inflammation through the reduced ROS-induced activation of NLRP3 pathway proteins.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115359 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Idiopathic Pulmonary Fibrosis (IPF) is a lung disease characterized by progressive scarring and currently lacks a cure, prompting the need for new therapeutic targets such as the cAMP pathway, particularly the protein Epac1.* -
- The study aimed to understand how Epac1 contributes to IPF progression by examining lung samples from IPF patients and preclinical models, alongside testing the effects of inhibiting Epac1 using a specific pharmacological agent, AM-001.* -
- Results showed that Epac1 levels were elevated in IPF tissue and fibroblasts, and inhibiting Epac1 led to reduced fibroblast proliferation and profibrotic signaling, indicating its potential role as a therapeutic target
Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor's anti-inflammatory effects.
Inflamm Res
November 2024
Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, 33328-2018, USA.
Background: Glucagon-like peptide (GLP)-1 receptor (GLP1R) agonists exert a multitude of beneficial cardiovascular effects beyond control of blood glucose levels and obesity reduction. They also have anti-inflammatory actions through both central and peripheral mechanisms. GLP1R is a G protein-coupled receptor (GPCR), coupling to adenylyl cyclase (AC)-stimulatory Gs proteins to raise cyclic 3`-5`-adenosine monophosphate (cAMP) levels in cells.
View Article and Find Full Text PDFDiesel exhaust particles alter mitochondrial bioenergetics and cAMP producing capacity in human bronchial epithelial cells.
Front Toxicol
July 2024
Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.
Air pollution from diesel combustion is linked in part to the generation of diesel exhaust particles (DEP). DEP exposure induces various processes, including inflammation and oxidative stress, which ultimately contribute to a decline in lung function. Cyclic AMP (cAMP) signaling is critical for lung homeostasis.
View Article and Find Full Text PDFNeuroprotective effect of omidenepag on excitotoxic retinal ganglion cell death regulating COX-2-EP2-cAMP-PKA/Epac pathway via Neuron-Glia interaction.
Neuroscience
August 2024
Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Article Synopsis
- Glutamate excitotoxicity contributes to the death of retinal ganglion cells (RGCs) in conditions like glaucoma and ischemia-reperfusion injury, causing both direct and indirect damage through inflammation.
- The study focused on Omidenepag (OMD), a new drug that lowers intraocular pressure and acts as an EP2 receptor agonist, investigating its potential neuroprotective effects against excitotoxic RGC death.
- OMD was found to significantly reduce RGC death and inflammatory responses in both in vitro and in vivo models, suggesting it promotes protective pathways while inhibiting harmful ones by improving interactions between glial cells and neurons.
Intracellular pathways of calcitonin gene-related peptide-induced relaxation of human coronary arteries: A key role for Gβγ subunit instead of cAMP.
Br J Pharmacol
August 2024
Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Background And Purpose: Calcitonin gene-related peptide (CGRP) is a potent vasodilator. While its signalling is assumed to be mediated via increases in cAMP, this study focused on elucidating the actual intracellular signalling pathways involved in CGRP-induced relaxation of human isolated coronary arteries (HCA).
Experimental Approach: HCA were obtained from heart valve donors (27 M, 25 F, age 54 ± 2 years).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!